Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab

Advances in Therapy

Volumn 26, Issue 2, 2009, Pages 208-216

  Lupinacci, Alvaro P C ^a   Calzada, Jorge I ^a,b   Rafieetery, Mohammad ^b   Charles, Steve ^a,b   Netland, Peter A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Charles Retina Institute   (United States)

Author keywords

Bevacizumab; Glaucoma drainage implants; Intraocular pressure; Neovascular glaucoma; Neovascularization inhibitors; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB;

ADULT; ANTERIOR EYE CHAMBER ANGLE; ANTERIOR EYE SEGMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE DISEASE; FEMALE; FOLLOW UP; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GONIOSCOPY; HEART TAMPONADE; HUMAN; INTRAOCULAR PRESSURE; MALE; OUTCOME ASSESSMENT; VISION; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHI-SQUARE DISTRIBUTION; FEMALE; GLAUCOMA, NEOVASCULAR; GONIOSCOPY; HUMANS; INJECTIONS, INTRAOCULAR; INTRAOCULAR PRESSURE; IRIS; LINEAR MODELS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 73449131518     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0001-1     Document Type: Article

References (19)

1. C.M. Andreoli J.W. Miller 2007 Anti-vascular endothelial growth factor therapy for ocular neovascular disease Curr Opin Ophthalmol. 18 502 508 18163003 10.1097/ICU.0b013e3282f0ca54 (Pubitemid 351339405)
2. S.S. Lynch C.M. Cheng 2007 Bevacizumab for neovascular ocular diseases Ann Pharmacother. 41 614 625 17355998 10.1345/aph.1H316 1:CAS:528: DC%2BD2sXltlOnsrs%3D (Pubitemid 46625484)
3. S. Grisanti S. Biester S. Peters 2006 Intracameral bevacizumab for iris rubeosis Am J Ophthalmol. 142 158 160 16815268 10.1016/j.ajo.2006.02.045 1:CAS:528:DC%2BD28Xms1Gktbo%3D (Pubitemid 43946796)
4. M.E. Iliev D. Domig U. Wolf-Schnurrbursch S. Wolf G.M. Sarra 2006 Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma Am J Ophthalmol. 142 1054 1056 17157590 10.1016/j.ajo.2006.06.066 1:CAS:528:DC%2BD28Xht12msLfM (Pubitemid 44853889)
5. J.O. Mason 3rd M.A. Albert Jr. A. Mays R. Vail 2006 Regression of neovascular iris vessels by intravitreal injection of bevacizumab Retina. 26 839 841 16963866 10.1097/01.iae.0000230425.31296.3b (Pubitemid 44386115)
6. A.S. Kelkar S.B. Kelkar J.A. Kelkar M. Nagpal S.P. Patil 2007 The use of intravitreal bevacizumab in neovascular glaucoma: a case report Bull Soc Belge Ophtalmol. 303 43 45 17894286
7. M.Y. Kahook J.S. Schuman R.J. Noecker 2006 Intravitreal bevacizumab in a patient with neovascular glaucoma Ophthalmic Surg Lasers Imaging. 37 144 146 16583637
8. F. Batioglu N. Astam E. Ozmert 2008 Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma Int Ophthalmol. 28 59 61 17609852 10.1007/s10792-007-9105-2 (Pubitemid 351308686)
9. J.F. Arevalo L. Wu J.G. Sanchez 2009 Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up Eye. 23 117 123 17891058 10.1038/sj.eye.6702980 1:CAS:528:DC%2BD1MXlvFGhuw%3D%3D
10. M.N. Chilov J.R. Grigg T.J. Playfair 2007 Bevacizumab (Avastin) for the treatment of neovascular glaucoma Clin Experiment Ophthalmol. 35 494 496 17651259 10.1111/j.1442-9071.2007.01521.x (Pubitemid 47162770)
11. F.H. Davidorf J.G. Mouser R.J. Derick 2006 Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection Retina. 26 354 356 16508439 10.1097/00006982-200603000-00017 (Pubitemid 44318196)
12. R.B. Bhisitkul 2006 Vascular endothelial growth factor biology: clinical implications for ocular treatments Br J Ophthalmol. 90 1542 1547 17114590 10.1136/bjo.2006.098426 1:STN:280:DC%2BD28nnsVynsg%3D%3D (Pubitemid 44862578)
13. S. Yazdani K. Hendi M. Pakravan 2007 Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma J Glaucoma. 16 437 439 17700285 10.1097/IJG.0b013e3180457c47 (Pubitemid 47263045)
14. Z. Vatavuk G. Bencic Z. Mandic 2007 Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion Eur J Ophthalmol. 17 269 271 17415704 1:STN:280:DC%2BD2s3htV2qtg%3D%3D
15. Y. Oshima H. Sakaguchi F. Gomi Y. Tano 2006 Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy Am J Ophthalmol. 142 155 158 16815267 10.1016/j.ajo.2006.02.015 1:CAS:528:DC%2BD28Xms1Gktbw%3D (Pubitemid 43946776)
16. T. Wakabayashi Y. Oshima H. Sakaguchi 2008 Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases Ophthalmology. 115 1571 1580 18440643 10.1016/j.ophtha.2008.02.026
17. N. Kitnarong P. Chindasub A. Metheetrairut 2008 Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma Adv Ther. 25 438 443 18425438 10.1007/s12325-008-0047-5 1:CAS:528: DC%2BD1cXhsVyqtL%2FJ
18. J.P. Ehlers M.J. Spirn A. Lam A. Sivalingam M.A. Samuel W. Tasman 2008 Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma Retina. 28 696 702 18463512 10.1097/IAE.0b013e3181679c0b (Pubitemid 351655121)
19. D.R. Hess 2004 Retrospective studies and chart reviews Respir Care. 49 1171 1174 15447798